within Pharmacolibrary.Drugs.ATC.V;

model V09CA03
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00011,
    adminDuration  = 600,
    adminMass      = 37 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00017999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 8.999999999999999e-05,
    k12             = 0.14,
    k21             = 0.14
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V09CA03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Technetium (99mTc) mertiatide is a radiopharmaceutical agent used in nuclear medicine for renal imaging studies (renography) to assess renal perfusion, function, and to aid in the diagnosis of renal obstruction. It is administered exclusively by intravenous injection and is approved for clinical use in the evaluation of kidney function.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult subjects with normal renal function. Data based on typical diagnostic doses and standard practice for nuclear renal scans.</p><h4>References</h4><ol><li><p>Lee, WG, et al., &amp; Choi, SH (2010). Renal uptakes of 99mTc-MAG3, 99mTc-DTPA, and 99mTc-DMSA in rabbits with unilateral ureteral obstruction. <i>In vivo (Athens, Greece)</i> 24(2) 137–139. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20363984/\">https://pubmed.ncbi.nlm.nih.gov/20363984</a></p></li><li><p>Coveney, JR, &amp; Robbins, MS (1987). Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 28(12) 1881–1887. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2960790/\">https://pubmed.ncbi.nlm.nih.gov/2960790</a></p></li><li><p>Mustafa, S, et al., &amp; Al Sagheer, F (2014). Effect of sulfa drugs on kidney function and renal scintigraphy. <i>Nephrology (Carlton, Vic.)</i> 19(4) 210–216. DOI:<a href=\"https://doi.org/10.1111/nep.12200\">10.1111/nep.12200</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24387277/\">https://pubmed.ncbi.nlm.nih.gov/24387277</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V09CA03;
